- Loblaw’s third-quarter adjusted earnings per share (EPS) were C$2.50, beating the estimate of C$2.45 and showing improvement from C$2.26 the previous year.
- Food retail comparable sales saw a small growth of 0.5% compared to a higher 4.5% the previous year.
- Drug retail comparable sales increased by 2.9%, down from a 4.6% increase last year.
- The company’s revenue rose by 1.5% year-over-year to C$18.54 billion, slightly below the estimated C$18.65 billion.
- Given the year-to-date performance, Loblaw is slightly boosting its full-year guidance for adjusted net earnings per share growth from high single-digits to low double-digits.
- Market analysts’ ratings include 7 buys, 3 holds, and 2 sells.
A look at Loblaw Cos Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
With Smartkarma Smart Scores indicating a promising long-term outlook for Loblaw Companies Limited, the Canadian retail and wholesale food distributor seems to be in a favorable position. The company’s strong growth and momentum scores, both at 4 out of 5, suggest positive traction in the market and potential for continued expansion. While Loblaw Cos may have average scores in terms of value, dividend, and resilience, its focus on growth and ability to maintain momentum demonstrate its competitiveness and potential for future success.
Loblaw Companies Limited, a prominent player in the Canadian retail and wholesale food distribution sector, is characterized by a widespread network of company and franchisee operated stores, warehouses, and cash and carry outlets. With its growth and momentum scores standing out at 4, Loblaw Cos is showing signs of resilience and potential for further development in the industry. While there may be room for improvement in areas such as value and dividends, the company’s overall outlook, as per the Smartkarma Smart Scores, seems promising for long-term investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
